Biogen (BIIB) Other Working Capital Changes (2011 - 2026)

Biogen has reported Other Working Capital Changes for 16 years, with the latest figure at $54.0 million in Q2 2026.

• On a quarterly basis, Other Working Capital Changes rose 145.45% year-over-year to $54.0 million in Q2 2026; TTM through Jun 2026 was $128.1 million, a 21250.0% increase from a year earlier, with the FY2025 full-year figure at $60.6 million, up 115.66% from the prior year.
• Other Working Capital Changes was $54.0 million for Q2 2026 at Biogen, down from $89.0 million in the prior quarter.
• The five-year high for Other Working Capital Changes was $213.6 million in Q1 2022, with the low at -$149.9 million in Q3 2022.
• Average Other Working Capital Changes over 5 years is $14.2 million, with a median of $28.4 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2025: Other Working Capital Changes slumped 1445.36% in 2022, then surged 379.89% in 2025.
• Over 5 years, Other Working Capital Changes stood at $34.9 million in 2022, then slumped by 291.4% to -$66.8 million in 2023, then soared by 43.71% to -$37.6 million in 2024, then plunged by 217.29% to -$119.3 million in 2025, then jumped by 145.26% to $54.0 million in 2026.
• The last three Other Working Capital Changes figures came in at $54.0 million (Q2 2026), $89.0 million (Q1 2026), and -$119.3 million (Q4 2025), per Business Quant data.